HC Wainwright Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) Stock
Insmed (NASDAQ:INSM – Get Free Report) had its target price boosted by research analysts at HC Wainwright from $90.00 to $120.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price objective points to a potential upside of 23.86% from the stock’s previous […]
Insmed (NASDAQ:INSM – Get Free Report) had its target price boosted by research analysts at HC Wainwright from $90.00 to $120.00 in a report issued on Wednesday,Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price objective points to a potential upside of 23.86% from the stock’s previous […]
